Trump's order on US drug prices: What's in it, and will it work?

The president promises sweeping price cuts "almost immediately", but experts say these are unlikely.

Watch LiveBritish Broadcasting CorporationHomeNewsSportBusinessInnovationCultureArtsTravelEarthAudioVideoLiveHomeNewsIsrael-Gaza WarWar in UkraineUS & CanadaUKUK PoliticsEnglandN. IrelandN. Ireland PoliticsScotlandScotland PoliticsWalesWales PoliticsAfricaAsiaChinaIndiaAustraliaEuropeLatin AmericaMiddle EastIn PicturesBBC InDepthBBC VerifySportBusinessExecutive LoungeTechnology of BusinessFuture of BusinessInnovationTechnologyScience & HealthArtificial IntelligenceAI v the MindCultureFilm & TVMusicArt & DesignStyleBooksEntertainment NewsArtsArts in MotionTravelDestinationsAfricaAntarcticaAsiaAustralia and PacificCaribbean & BermudaCentral AmericaEuropeMiddle EastNorth AmericaSouth AmericaWorld’s TableCulture & ExperiencesAdventuresThe SpeciaListEarthNatural WondersWeather & ScienceClimate SolutionsSustainable BusinessGreen LivingAudioPodcastsRadioAudio FAQsVideoLiveLive NewsLive SportHomeNewsSportBusinessInnovationCultureArtsTravelEarthAudioVideoLiveWeatherNewslettersWatch LiveTrump's order on US drug prices: What's in it, and will it work?3 days agoShareSaveMike Wendling and Laura BlaseyBBC NewsShareSaveWatch: Trump to "equalise" drug prices between the US and other countriesUS President Donald Trump has signed an executive order that aims to reduce high prescription drug prices – but its details and long-term effects are far from clear.

Citing figures that patients in other countries pay much less than Americans for pharmaceuticals, Trump said he would order drug companies to reduce their prices inside the US.

He touted the move as "one of the most consequential" executive orders in US history, claiming prices would fall "almost immediately, by 30% to 80%".

But experts are highly sceptical of the claims, and stock market moves indicate that investors think they will have little immediate effect.

The US has a particularly complex healthcare system - including a large private insurance industry, employer subsidies, and publicly funded insurance programmes for the elderly and poor, known as Medicare and Medicaid respectively.